中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Cardioprotection and Matrix Metalloproteinase-9 Regulation of Salvianolic Acids on Myocardial Infarction in Rats

文献类型:期刊论文

作者Jiang, Baohong; Wu, Wanying; Li, Ming; Xu, Lingling; Sun, Kejia; Yang, Min; Guan, Shuhong; Liu, Xuan; Guo, De-an
刊名PLANTA MEDICA
出版日期2009-10
卷号75期号:12页码:1286-1292
关键词Salvia miltiorrhiza Labiatae salvianolic acids acute myocardial infarction matrix metalloproteinase-9 cardioprotection
ISSN号0032-0943
DOI10.1055/s-0029-1185669
文献子类Article
英文摘要Acute myocardial infarction (AMI) remains the leading cause of mortality in the world. Early intervention using salvianolic acids (SA) can substantially improve clinical outcomes. However, in spite of the great achievements that have been made in elucidating the protective effects of SA on AMI the effects of SA on the contractile performance of the left ventricle (LV) and the underlying mechanism are still not so clear. In the present study, AMI was introduced by ligation of the left anterior descending coronary artery near the main pulmonary artery. Administration of SA significantly decreased infarct size, improved LV function and appearance of the myocardium and decreased myocardial malondialdehyde levels compared with the AMI group. Furthermore, treatment with SA significantly downregulated the mRNA expression level and activity of matrix metalloproteinase-9 (MMP-9), but did not regulate the tissue inhibitor of metalloproteinase-1 (TIMP-1) expression level at the infarct area. Lisinopril (an angiotensin converting enzyme inhibitor), which holds potential effects on cardioprotection, was chosen as the positive control in this study. Lisinopril elevated LV function and appearance of the myocardium, decreased malondialdehyde levels without an influence on infarct size, and regulated the MMP-9 enzyme level but not the MMP-9 mRNA and TIMP-1 protein levels. These findings suggest that early SA treatment is effective to improve LV function; and SA may exert preventative effects against myocardial remodeling after infarction.
WOS关键词MATRIX METALLOPROTEINASES ; CELLS ; EXPRESSION ; MICE ; SUPPRESSION ; INHIBITION ; INDUCTION ; STRESS ; HEART ; MMP-9
资助项目International Science and Technology Cooperation[2006DFB31860] ; Ministry of Science and Technology of China[2006BA1081303-03]
WOS研究方向Plant Sciences ; Pharmacology & Pharmacy ; Integrative & Complementary Medicine
语种英语
WOS记录号WOS:000271098300002
出版者GEORG THIEME VERLAG KG
源URL[http://119.78.100.183/handle/2S10ELR8/279120]  
专题上海中药现代化研究中心
通讯作者Guo, De-an
作者单位Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai Res Ctr Modernizat Tradit Chinese Med, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China
推荐引用方式
GB/T 7714
Jiang, Baohong,Wu, Wanying,Li, Ming,et al. Cardioprotection and Matrix Metalloproteinase-9 Regulation of Salvianolic Acids on Myocardial Infarction in Rats[J]. PLANTA MEDICA,2009,75(12):1286-1292.
APA Jiang, Baohong.,Wu, Wanying.,Li, Ming.,Xu, Lingling.,Sun, Kejia.,...&Guo, De-an.(2009).Cardioprotection and Matrix Metalloproteinase-9 Regulation of Salvianolic Acids on Myocardial Infarction in Rats.PLANTA MEDICA,75(12),1286-1292.
MLA Jiang, Baohong,et al."Cardioprotection and Matrix Metalloproteinase-9 Regulation of Salvianolic Acids on Myocardial Infarction in Rats".PLANTA MEDICA 75.12(2009):1286-1292.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。